Rationalizing the pathway to personalized neoadjuvant immunotherapy: the Lombard Street Approach

por Versluis, Judith M, Thommen, Daniela S, Blank, Christian U
Publicado 2020

Protocol for ex vivo culture of patient-derived tumor fragments

por Roelofsen, Lisanne M., Voabil, Paula, de Bruijn, Marjolein, Herzig, Petra, Zippelius, Alfred, Schumacher, Ton N., Thommen, Daniela S.
Publicado 2023

Long-distance modulation of bystander tumor cells by CD8(+) T cell-secreted IFNγ

por Hoekstra, Mirjam E., Bornes, Laura, Dijkgraaf, Feline E., Philips, Daisy, Pardieck, Iris N., Toebes, Mireille, Thommen, Daniela S., van Rheenen, Jacco, Schumacher, Ton N.M.
Publicado 2020

Dual Immune Checkpoint Blockade Induces Analogous Alterations in the Dysfunctional CD8(+) T-cell and Activated Treg Compartment

por van der Leun, Anne M., Traets, Joleen J.H., Vos, Joris L., Elbers, Joris B.W., Patiwael, Sanne, Qiao, Xiaohang, Machuca-Ostos, Mercedes, Thommen, Daniela S., Haanen, John B.A.G., Schumacher, Ton N.M., Zuur, Charlotte L.
Publicado 2023

Antibody Phage Display Assisted Identification of Junction Plakoglobin as a Potential Biomarker for Atherosclerosis

por Cooksley-Decasper, Seraina, Reiser, Hans, Thommen, Daniela S., Biedermann, Barbara, Neidhart, Michel, Gawinecka, Joanna, Cathomas, Gieri, Franzeck, Fabian C., Wyss, Christophe, Klingenberg, Roland, Nanni, Paolo, Roschitzki, Bernd, Matter, Christian, Wolint, Petra, Emmert, Maximilian Y., Husmann, Marc, Amann-Vesti, Beatrice, Maier, Wilibald, Gay, Steffen, Lüscher, Thomas F., von Eckardstein, Arnold, Hof, Danielle
Publicado 2012

Single Cell Analysis of Regions of Interest (SCARI) using a photo-sensitive tag

por van der Leun, Anne M., Hoekstra, Mirjam E., Reinalda, Luuk, Scheele, Colinda L.G.J., Toebes, Mireille, van de Graaff, Michel J., Chen, Linda Y.Y., Li, Hanjie, Bercovich, Akhiad, Lubling, Yaniv, David, Eyal, Thommen, Daniela S., Tanay, Amos, van Rheenen, Jacco, Amit, Ido, van Kasteren, Sander I., Schumacher, Ton N.
Publicado 2021

Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer

por Trüb, Marta, Uhlenbrock, Franziska, Claus, Christina, Herzig, Petra, Thelen, Martin, Karanikas, Vaios, Bacac, Marina, Amann, Maria, Albrecht, Rosemarie, Ferrara-Koller, Claudia, Thommen, Daniela, Rothschield, Sacha, Savic Prince, Spasenija, Mertz, Kirsten D, Cathomas, Gieri, Rosenberg, Robert, Heinzelmann-Schwarz, Viola, Wiese, Mark, Lardinois, Didier, Umana, Pablo, Klein, Christian, Laubli, Heinz, Kashyap, Abhishek S, Zippelius, Alfred
Publicado 2020

PD-1(T) TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC

por Hummelink, Karlijn, van der Noort, Vincent, Muller, Mirte, Schouten, Robert D., Lalezari, Ferry, Peters, Dennis, Theelen, Willemijn S.M.E., Koelzer, Viktor H., Mertz, Kirsten D., Zippelius, Alfred, van den Heuvel, Michel M., Broeks, Annegien, Haanen, John B.A.G., Schumacher, Ton N., Meijer, Gerrit A., Smit, Egbert F., Monkhorst, Kim, Thommen, Daniela S.
Publicado 2022

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

por Trefny, Marcel P., Kirchhammer, Nicole, Auf der Maur, Priska, Natoli, Marina, Schmid, Dominic, Germann, Markus, Fernandez Rodriguez, Laura, Herzig, Petra, Lötscher, Jonas, Akrami, Maryam, Stinchcombe, Jane C., Stanczak, Michal A., Zingg, Andreas, Buchi, Melanie, Roux, Julien, Marone, Romina, Don, Leyla, Lardinois, Didier, Wiese, Mark, Jeker, Lukas T., Bentires-Alj, Mohamed, Rossy, Jérémie, Thommen, Daniela S., Griffiths, Gillian M., Läubli, Heinz, Hess, Christoph, Zippelius, Alfred
Publicado 2023

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

por Váraljai, Renáta, Zimmer, Lisa, Al-Matary, Yahya, Kaptein, Paulien, Albrecht, Lea J., Shannan, Batool, Brase, Jan C., Gusenleitner, Daniel, Amaral, Teresa, Wyss, Nina, Utikal, Jochen, Flatz, Lukas, Rambow, Florian, Reinhardt, Hans Christian, Dick, Jenny, Engel, Daniel R., Horn, Susanne, Ugurel, Selma, Sondermann, Wiebke, Livingstone, Elisabeth, Sucker, Antje, Paschen, Annette, Zhao, Fang, Placke, Jan M., Klose, Jasmin M., Fendler, Wolfgang P., Thommen, Daniela S., Helfrich, Iris, Schadendorf, Dirk, Roesch, Alexander
Publicado 2023

Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma

por Váraljai, Renáta, Zimmer, Lisa, Al-Matary, Yahya, Kaptein, Paulien, Albrecht, Lea J., Shannan, Batool, Brase, Jan C., Gusenleitner, Daniel, Amaral, Teresa, Wyss, Nina, Utikal, Jochen, Flatz, Lukas, Rambow, Florian, Reinhardt, Hans Christian, Dick, Jenny, Engel, Daniel R., Horn, Susanne, Ugurel, Selma, Sondermann, Wiebke, Livingstone, Elisabeth, Sucker, Antje, Paschen, Annette, Zhao, Fang, Placke, Jan M., Klose, Jasmin M., Fendler, Wolfgang P., Thommen, Daniela S., Helfrich, Iris, Schadendorf, Dirk, Roesch, Alexander
Publicado 2023

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research

por Alspach, Elise, Chow, Ryan D., Demehri, Shadmehr, Guerriero, Jennifer L., Gujar, Shashi, Hartmann, Felix J., Helmink, Beth A., Hudson, William H., Ho, Won Jin, Ma, Leyuan, Maier, Barbara B., Maltez, Vivien I., Miller, Brian C., Moran, Amy E., Parry, Erin M., Pillai, Padmini S., Rafiq, Sarwish, Reina-Campos, Miguel, Rosato, Pamela C., Rudqvist, Nils-Petter, Ruhland, Megan K., Sagiv-Barfi, Idit, Sahu, Avinash Das, Samstein, Robert M., Schürch, Christian M., Sen, Debattama R., Thommen, Daniela S., Wolf, Yochai, Zappasodi, Roberta
Publicado 2021